Retension Pharmaceuticals names Robert Wong chief accounting officer
The Nasdaq-listed company said Wong will start as VP and principal accounting officer on November 2, 2026, with a base salary of $360,000.
SEC filing
Latest
2 stories
Thursday, October 22
Friday, October 9
Beyond Air preannounces $2.3 million revenue, reaffirms 2026 and 2027 guidance
The company said LungFit PH sales rose on commercial execution gains while its second-generation system stays under FDA review.
SEC filing (2)